MAYWOOD, Ill. - Dr. Patrick Stiff of Loyola University Medical Center has been named chairman of a nationwide committee of cancer researchers who design and conduct clinical trials involving bone marrow and stem cell transplants.
Such transplants treat blood and lymph cancers, including leukemia, lymphoma, and multiple myeloma.
The committee includes 86 investigators from many of the nation’s top cancer centers. It’s named the SWOG Bone Marrow and Stem Cell Transplantation Committee. SWOG, formerly known as the Southwest Oncology Group, designs and conducts multidisciplinary clinical trials to improve the practice of medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors.
Stiff has served as vice chairman of the Bone Marrow and Stem Cell Transplantation Committee since 2000. “He is eminently qualified to now become its overall leader,” said Dr. Charles D. Blanke, SWOG chairman. “He is also the SWOG principal investigator for Loyola University, and hence knows our group well."
Stiff is division director of Hematology/Oncology and medical director of Loyola’s Cardinal Bernardin Cancer Center. He is a professor in the departments of Hematology/Oncology and Pathology of Loyola University Chicago Stritch School of Medicine.
Loyola has treated more blood cancer patients with stem cell transplants than any other center in Illinois and has one of the largest unrelated donor transplant programs in the world. Loyola physicians have performed more than 2,700 stem cell transplants, including about 150 cord blood transplants. Loyola has particular expertise in treating patients who cannot find matching donors from either their families or the National Marrow Donor Program. Loyola receives referrals from throughout the Midwest, including other academic medical centers in Chicago. Loyola is among the first centers to use umbilical cord donations for the treatment of certain adult cancers.